- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gastric Cancer in Brazil
Total 865 results
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineRecruitingEndometrial CancerBrazil
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Columbia UniversityInternational Agency for Research on CancerRecruitingAcute Lymphoblastic Leukemia | Nutrition Aspect of Cancer | Genetic Predisposition | MicrotiaUnited States, Guatemala, Brazil, Honduras, India, Tanzania
-
SanofiActive, not recruitingNon-squamous Non-small-cell Lung Cancer (NSQ NSCLC)Spain, United States, Brazil, Chile, Czechia, France, Hungary, Israel
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
WestatEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSickle Cell Disease | Thalassemia | Pediatric CancerUnited States, Brazil
-
Bristol-Myers SquibbNo longer availableNon-squamous Non-Small Cell Lung Cancer | Squamous Non-Small Cell Lung CancerBrazil, Canada
-
Queensland Centre for Gynaecological CancerThe University of QueenslandRecruitingSurgery | Sentinel Lymph Node | Endometrial Cancer Stage IAustralia, United States, Brazil, Singapore, India
-
Hoffmann-La RocheCompletedBreast CancerFrance, Italy, Spain, Turkey, Brazil, India
-
Latin American Cooperative Oncology GroupMinistry of Health, Brazil; Avon InstituteCompleted
-
Jules Bordet InstituteActive, not recruitingBreast CancerUnited States, Belgium, Israel, France, Italy, Spain, Brazil, Mexico, Poland, Portugal, Switzerland
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
International Atomic Energy AgencyCompletedCervix CancerPeru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IA2 Cervical Cancer AJCC v6 and v7 | Stage IB1 Cervical Cancer AJCC v6 and v7United States, Brazil, Colombia, Peru, Mexico, Argentina, Australia, Thailand
-
Nereus Pharmaceuticals, Inc.CompletedCancerUnited States, Australia, India, Chile, Brazil, Argentina
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hospital Moinhos de VentoRecruiting
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBreast CancerUnited States, South Africa, Canada, Argentina, Chile, Bulgaria, Croatia, Netherlands, Estonia, Denmark, Poland, Brazil, Mexico, Romania
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Daiichi Sankyo, Inc.CompletedColorectal Cancer | Neoplasms, ColorectalUnited States, Peru, Chile, Argentina, Brazil
-
Hoffmann-La RocheRecruitingUrothelial CancerKorea, Republic of, United States, Brazil, China, France, Germany, Mexico, Poland, Denmark, Italy, Turkey, Greece, Spain, United Kingdom, Australia
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, Germany, Korea, Republic of, Brazil, Poland, Russian Federation, Turkey, Spain, Australia, France, Canada, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingDifferentiated Thyroid CancerChina, Canada, Taiwan, India, Korea, Republic of, Turkey, Malaysia, Vietnam, Brazil, United States, Argentina
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Recombio SLEurofarma Laboratorios S.A.; Laboratorio Elea Phoenix S.A.; Innogene Kalbiotech... and other collaboratorsUnknownNSCLC | Lung Cancer, Non-small CellBrazil, Indonesia, Argentina, Cuba, Philippines, Singapore, Thailand
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Colorectal CancerUnited Kingdom, Spain, Germany, Poland, Australia, Belgium, Brazil, Denmark, France, Italy, Netherlands, Russian Federation
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Latin American Cooperative Oncology GroupRoche Pharma AG; EVA - Grupo Brasileiro de Tumores GinecológicosCompleted
-
Hoffmann-La RocheLatin American Cooperative Oncology GroupActive, not recruitingBreast CancerColombia, Guatemala, Argentina, Brazil, Chile, Cuba, Mexico, Peru, Uruguay, Dominican Republic
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Brazil, Mexico, Portugal
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Eurofarma Laboratorios S.A.CompletedAdenocarcinoma | Esophageal CancerBrazil
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Libbs Farmacêutica LTDAActive, not recruitingBreast CancerBrazil
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
AstraZenecaTerminatedDifferentiated Thyroid CancerUnited States, Denmark, Italy, Sweden, Poland, Brazil, France, Germany
-
Eisai Inc.PharmaBio Development Inc.TerminatedRectal Cancer | Colon CancerArgentina, Russian Federation, United States, Australia, Brazil, Ukraine
-
ETOP IBCSG Partners FoundationCompletedBreast CancerItaly, Switzerland, Australia, Peru, South Africa, Chile, Belgium, Brazil, Romania, Hungary, Nigeria
-
Agenus Inc.Active, not recruitingMetastatic Colorectal CancerUnited States, France, Belgium, Spain, Italy, Brazil, Russian Federation, Georgia
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
Spectrum Pharmaceuticals, IncCompletedNon-small Cell Lung CancerUnited States, Czechia, India, Brazil, Argentina, Hungary